Rodney W. Lappe, Director at Design Therapeutics, Inc. (DSGN), bought 21,000 shares at $2.35 ($49K) on 2023-09-29, disclosed to the SEC on 2023-10-02.
Open-market purchase of $49k DSGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |